News

Tesamorelin is a growth hormone-releasing factor (GRF) analogue that induces growth hormone production and its anabolic properties have led Theratechnologies to pursue its development in muscle wasting in

AT-406 is an orally available small molecule helps in neutralizing major inhibitors of apoptosis and is anticipated to be effective in treating cancers in conjunction with anti-cancer therapies.

Buccolam is indicated for the treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents, from 3 months to less than 18 years of age. Buccal

The trial is aimed to investigate the safety, pharmacokinetics and tolerability of BAL30072 following multiple ascending intravenous infusions in healthy volunteers. BAL30072 demonstrated safety and tolerability profile in

Haloperidol Injection, USP is also indicated for the control of tics and vocal utterances of Tourette’s disorder. Sagent’s haloperidol injection will be offered in 5mg per ml single-dose

Following the acquisition, the joint ventures will be completely owned by Biogen and will be named as Biogen Idec Italia and Biogen Idec Switzerland. The joint venture collaboration

The Veeva CRM suite consists of VBioPharma, VMobile, and VInsights, iRep for closed loop marketing on the iPad. Veeva CRM improves user adoption and sales effectiveness, while reducing

Initially, BARDA will give $38.5m to GSK over two years to develop GSK2251052, an investigational antibiotic against bacterial enzyme leucyl tRNA synthetase. The funding is expected to support

The trial aims to compare the safety and efficacy of masitinib at 6mg/kg/day with placebo in patients with primary progressive multiple sclerosis or relapse free secondary progressive multiple